Skip to content
← Full study record

NCT00887809 · MORE INFO

Limitations, agreements, and source contact

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes · Source last updated 2016-01-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
tapw@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-888-4163
title
Dr. William Tap
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
tapw@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-888-4163
title
Dr. William Tap

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice